Literature DB >> 18279779

Insulin and carbohydrate metabolism.

Kathryn Beardsall1, Barbro M S Diderholm, David B Dunger.   

Abstract

Fetal glucose exposure and consequent fetal insulin secretion is normally tightly regulated by glucose delivery from the mother during pregnancy. Maternal hyperglycaemia and gestational diabetes (GDM) are known to be detrimental to offspring, although defining the criteria for diagnosis of GDM is controversial. Recent data suggest that the risk of poor fetal outcome appears to be a continuous variable across the range of glucose control, and that the level of maternal blood glucose for a diagnosis of gestational diabetes needs to be reviewed. After birth, rapid adaptation is necessary for infants to be able to maintain independent glucose homeostasis. This adaptation is compromised in infants who are small for gestational age (SGA), premature, or large for gestational age (LGA). Interestingly, the infants who are born at the extremes of birth weight are also at increased risk of impaired glucose tolerance and diabetes in later life.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18279779     DOI: 10.1016/j.beem.2007.10.001

Source DB:  PubMed          Journal:  Best Pract Res Clin Endocrinol Metab        ISSN: 1521-690X            Impact factor:   4.690


  9 in total

Review 1.  Gestational Diabetes Mellitus and Energy-Dense Diet: What Is the Role of the Insulin/IGF Axis?

Authors:  Irene Martín-Estal; Fabiola Castorena-Torres
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-23       Impact factor: 6.055

2.  Predictors of severe postoperative hyperglycemia after cardiac surgery in infants: a single-center, retrospective, observational study.

Authors:  Natsuhiro Yamamoto; Tomoya Irie; Shunsuke Takaki; Osamu Yamaguchi; Takahisa Goto
Journal:  J Anesth       Date:  2018-01-12       Impact factor: 2.078

3.  Maternal Midpregnancy Glucose Levels and Risk of Congenital Heart Disease in Offspring.

Authors:  James R Priest; Wei Yang; Gerald Reaven; Joshua W Knowles; Gary M Shaw
Journal:  JAMA Pediatr       Date:  2015-12       Impact factor: 16.193

4.  Fetal exposure to altered amniotic fluid glucose, insulin, and insulin-like growth factor-binding protein 1 occurs before screening for gestational diabetes mellitus.

Authors:  Daniel K Tisi; David H Burns; Gary W Luskey; Kristine G Koski
Journal:  Diabetes Care       Date:  2010-09-20       Impact factor: 19.112

5.  Decreased KATP Channel Activity Contributes to the Low Glucose Threshold for Insulin Secretion of Rat Neonatal Islets.

Authors:  Juxiang Yang; Batoul Hammoud; Changhong Li; Abigail Ridler; Daphne Yau; Junil Kim; Kyoung-Jae Won; Charles A Stanley; Toshinori Hoshi; Diana E Stanescu
Journal:  Endocrinology       Date:  2021-09-01       Impact factor: 5.051

6.  Shape information in repeated glucose curves during pregnancy provided significant physiological information for neonatal outcomes.

Authors:  Kathrine Frey Frøslie; Jo Røislien; Elisabeth Qvigstad; Kristin Godang; Jens Bollerslev; Tore Henriksen; Marit B Veierød
Journal:  PLoS One       Date:  2014-03-11       Impact factor: 3.240

7.  Effect of different maternal metabolic characteristics on fetal growth in women with gestational diabetes mellitus.

Authors:  Laleh Eslamian; Soheila Akbari; Vajihe Marsoosi; Ashraf Jamal
Journal:  Iran J Reprod Med       Date:  2013-04

8.  Targeting glucose control in preterm infants: pilot studies of continuous glucose monitoring.

Authors:  Lynn Thomson; Daniela Elleri; Simon Bond; James Howlett; David B Dunger; Kathryn Beardsall
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2018-09-19       Impact factor: 5.747

9.  Performance of whole-genome promoter nucleosome profiling of maternal plasma cell-free DNA for prenatal noninvasive prediction of fetal macrosomia: a retrospective nested case-control study in mainland China.

Authors:  Qianwen Lu; Zhiwei Guo; Jun Zhang; Ke Wang; Qi Tian; Siping Liu; Kun Li; Cailing Xu; Caimin Li; Zenglu Lv; Zhigang Zhang; Xuexi Yang; Fang Yang
Journal:  BMC Pregnancy Childbirth       Date:  2022-09-10       Impact factor: 3.105

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.